TS
Thoom Srividya
About Thoom Srividya
Data last updated:
Thoom Srividya is a Director at Vedicmolecule Private Limited (since 2024), Director at Quantumgensis Private Limited (since 2024) and Director at Vidazan Therapeutics Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Professional Services, Paper and Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Aug 2024 | 2024 | Active | ||
| Director | 29 Aug 2024 | 2024 | Active | ||
| Director | 16 Oct 2023 | 2023 | Active | ||
| Director | 08 Sep 2022 | 2022 | Active | ||
| Director | 01 Feb 2022 | 2022 | Active |
Board colleagues of Thoom Srividya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramalaxmareddy Kandimalla | 09488223 | Vedicmolecule Private Limited , Quantumgensis Private Limited and 1 more | Director |
| Sunitha Thalugula | 09719200 | Vidazan Therapeutics Private Limited , Zaney Neutra Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thoom Srividya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thoom Srividya
Thoom Srividya currently holds 5 directorships: Vedicmolecule Private Limited (Director, since 30 Aug 2024); Quantumgensis Private Limited (Director, since 29 Aug 2024); Vidazan Therapeutics Private Limited (Director, since 16 Oct 2023); Zaney Neutra Private Limited (Director, since 08 Sep 2022); R9 Pharma Technologies Private Limited (Director, since 01 Feb 2022).
Thoom Srividya was first appointed on 01 Feb 2022 as Director at R9 Pharma Technologies Private Limited. The most recent appointment on record is 30 Aug 2024 at Vedicmolecule Private Limited.
The current boards of Thoom Srividya's companies include Ramalaxmareddy Kandimalla (Vedicmolecule Private Limited), Sunitha Thalugula (Vidazan Therapeutics Private Limited).